Live Breaking News & Updates on Nasopharyngeal Cancer

Stay updated with breaking news from Nasopharyngeal cancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Nasopharyngeal Cancer rates among Bidayuh community highest in the world, says S'wak deputy health director

KUCHING (Oct 1): The Nasopharyngeal Cancer (NPC) rates among the Bidayuh community in Sarawak are the highest not just in Malaysia but across the globe, Sarawak Deputy Health Director Dr Veronica Lugah disclosed.

The finding was unveiled during the ‘Aku Ingin Hidup’ discourse organised by the Can ....

Kuala Lumpur , Jaya Sapetar , Veronica Lugah , Norhafrina Suni , Chris Cheng Hodgkin , Salamiah Hassan , Zuraini Kamal , Melissa Francis , Chopie Cakap , Syakirah Basri , Mohamad Ali Kupon , Nizam Laksamana , Sarawak Deputy Health , Society For Cancer Advocacy , Nasopharyngeal Cancer , Aku Ingin Hidup , Cancer Survivors Malaysia , Follicular Lymphoma Cancer Survivor , Cancer Advocacy , Awareness Sarawak , Chris Cheng , Survivors Malaysia , Aku Ingin Hidup ,

Novel biomarker derived from EBV promising for mass screening for nasopharyngeal cancer: NEJM

China: A recent study has shown anti–BNLF2b total antibody (P85-Ab) to be a promising novel biomarker for screening of nasopharyngeal carcinoma, with higher specificity, sensitivity, and positive. ....

Ningshao Xia , Key Laboratory Of Vaccines , Xiamen University , State Key Laboratory , Infectious Diseases , Epstein Barr Virus , Mass Screening , New England Journal Of Medicine , Nasopharyngeal Cancer , Cancer Screening , Epstein Barr Virus , 85 Ab , Novel Biomarker ,

Blood test developed by Hong Kong researchers can detect nasopharyngeal cancer risk in asymptomatic patients, Chinese University says

Study participants with persistently positive test results are 17 times more likely to get disease later in life, researchers say. ....

Cancer Screening , Rose Cancer , Nasopharyngeal Cancer , Na Screening For Cancer , Hong Kong Health ,

Synergy Of Coherus And Surface Oncology: Analyst Forecasts $50M Savings And 2024 Profitability - Coherus BioSciences (NASDAQ:CHRS)

Truist Securities analyst Robyn Karnauskas reiterated a Buy rating on the shares of Coherus BioSciences, Inc. ....

Coherus Biosciences , Robyn Karnauskas , Coherus Biosciences Inc , Truist Securities , Surface Oncology , Nasopharyngeal Cancer ,

Dual immunotherapy promising for treatment of recurrent or metastatic nasopharyngeal cancer

Singapore: The dual immunotherapy, PD-1 immune checkpoint inhibitor nivolumab and CTLA-4 targeting drug ipilimumab effectively treat recurrent or metastatic nasopharyngeal carcinoma (NPC), a recent. ....

Gopal Iyer , National Taiwan University , Nature Communications , Institute Of Molecular , Division Of Surgery , Genome Institute Of Singapore , National Cancer Centre Singapore , Department Of Lung , Division Of Medical Oncology , Department Of Head , Singapore General Hospital , Cell Biology , Genome Institute , National University , Cancer Science Institute , Southern Chinese , Associate Professor Darren Lim , Senior Consultant , Genitourinary Medical Oncology , Medical Oncology , Professor Gopal Iyer , Neck Surgery , Surgical Oncology , Nasopharyngeal Cancer , Immune Checkpoint Inhibitor Nivolumab ,